Anna Jaromin, Robert Zarnowski, Adam Markowski, Agnieszka Zagórska, Chad J Johnson, Haniyeh Etezadi, Shinji Kihara, Pablo Mota-Santiago, Jeniel E Nett, Ben J Boyd, David R Andes
The newly emerged pathogen, Candida auris , presents a serious threat to public health worldwide. This multidrug-resistant yeast often colonizes and persists on the skin of patients, can easily spread from person to person, and can cause life-threatening systemic infections. New antifungal therapies are therefore urgently needed to limit and control both superficial and systemic C. auris infections. In this study, we designed a novel antifungal agent, PQA-Az-13, that contains a combination of indazole, pyrrolidine, and arylpiperazine scaffolds substituted with a trifluoromethyl moiety...
December 11, 2023: Antimicrobial Agents and Chemotherapy